The mechanism of action of Kahalalide F: Variable cell permeability in human hepatoma cell lines

European Journal of Cancer

Volumn 41, Issue 11, 2005, Pages 1637-1644

  Sewell, J M ^a,b   Mayer, I ^a   Langdon, S P ^a   Smyth, J F ^a   Jodrell, D I ^a   Guichard, S M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Apoptosis; Cytotoxic peptide; Hepatoma cell lines; Membrane permeability; Necrosis; Oncosis

Indexed keywords

KAHALALIDE F; LACTATE DEHYDROGENASE; LIPOCORTIN 5; NATURAL PRODUCT; PEPTIDE DERIVATIVE; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; GENETIC VARIABILITY; HEPATOMA CELL; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN DEPLETION;

ADENOSINE TRIPHOSPHATE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MEMBRANE; DEPSIPEPTIDES; HUMANS; LIVER NEOPLASMS; PERMEABILITY;

EID: 22144492575     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.04.015     Document Type: Article

References (23)

1. J.I. Kourie, and A.A. Shorthouse Properties of cytotoxic peptide-formed ion channels Am J Physiol Cell Physiol 278 6 2000 C1063 C1087
2. L. Kissau, P. Stahl, and R. Mazitschek Development of natural product-derived receptor tyrosine kinase inhibitors based on conservation of protein domain fold J Med Chem 46 14 2003 2917 2931
3. M. Garcia-Rocha, P. Bonay, and J. Avila The antitumoral compound Kahalalide F acts on cell lysosomes Cancer Lett 99 1 1996 43 50
4. Y. Suarez, L. Gonzalez, and A. Cuadrado A new marine-derived compound, induces oncosis in human prostate and breast cancer cells Mol Cancer Ther 2 9 2003 863 872
5. G. Faircloth, W. Grant, and B. Smith Preclinical development of Kahalalide F, a new marine compound selected for clinical studies Proc Am Ass Cancer Res 42 2000 213
6. C. Ciruelos, T. Trigo, and J. Pardo A phase I clinical and pharmacokinetic (PK) study with KahalalideF (KF) in patients (pts) with advanced solid tumors (AST) with a continuous weekly (W) 1-hour iv infusion schedule Eur J Cancer 38 Suppl. 7 2002 33
7. J.M. Rademaker-Lakhai, S. Horenblas, and W. Meinhardt Phase I clinical and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancer Clin Cancer Res 11 5 2005 1854 1862
8. J.J. Lemasters, A.L. Nieminen, and T. Qian The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy Biochim Biophys Acta 1366 1-2 1998 177 196
9. G. Majno, and I. Joris Apoptosis, oncosis, and necrosis. An overview of cell death Am J Pathol 146 1 1995 3 15
10. Y. Eguchi, S. Shimizu, and Y. Tsujimoto Intracellular ATP levels determine cell death fate by apoptosis or necrosis Cancer Res 57 10 1997 1835 1840
11. Y. Nishimura, and J.J. Lemasters Glycine blocks opening of a death channel in cultured hepatic sinusoidal endothelial cells during chemical hypoxia Cell Death Differ 8 8 2001 850 858
12. M. Estacion, and W.P. Schilling Blockade of maitotoxin-induced oncotic cell death reveals zeiosis BMC Physiol 2 1 2002 2
13. T. O'Brien, G. Babcock, and J. Cornelius A comparison of apoptosis and necrosis induced by hepatotoxins in HepG2 cells Toxicol Appl Pharmacol 164 3 2000 280 290
14. W.X. Zong, D. Ditsworth, and D.E. Bauer Alkylating DNA damage stimulates a regulated form of necrotic cell death Genes Dev 18 11 2004 1272 1282 Epub 2004 May 14
15. A.D. Lewis, J.D. Hayes, and C.R. Wolf Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects Carcinogenesis 9 7 1988 1283 1287
16. H. Lecoeur, M.C. Prevost, and M.L. Gougeon Oncosis is associated with exposure of phosphatidylserine residues on the outside layer of the plasma membrane: a reconsideration of the specificity of the annexin V/propidium iodide assay Cytometry 44 1 2001 65 72
17. B.B. Knowles, C.C. Howe, and D.P. Aden Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen Science 209 4455 1980 497 499
18. G.M. MacNab, J.J. Alexander, and G. Lecatsas Hepatitis B surface antigen produced by a human hepatoma cell line Br J Cancer 34 5 1976 509 515
19. H. Jaeschke, and J.J. Lemasters Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury Gastroenterology 125 4 2003 1246 1257
20. D. Gramaglia, A. Gentile, and M. Battaglia Apoptosis to necrosis switching downstream of apoptosome formation requires inhibition of both glycolysis and oxidative phosphorylation in a BCL-X(L)-and PKB/AKT-independent fashion Cell Death Differ 11 3 2004 342 353
21. Z. Dong, Y. Patel, and P. Saikumar Development of porous defects in plasma membranes of adenosine triphosphate-depleted Madin-Darby canine kidney cells and its inhibition by glycine Lab Invest 78 6 1998 657 668
22. W.P. Schilling, T. Wasylyna, and G.R. Dubyak Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore Am J Physiol 277 4 Pt 1 1999 C766 C776
23. M. Estacion, J.S. Weinberg, and W.G. Sinkins Blockade of maitotoxin-induced endothelial cell lysis by glycine and l-alanine Am J Physiol Cell Physiol 284 4 2003 C1006 C1020